Reach Us +441202068036
Insomnia Symptom Presentation and Sleep Aids | OMICS International
ISSN: 2167-0277
Journal of Sleep Disorders & Therapy
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Insomnia Symptom Presentation and Sleep Aids

Kathy Sexton-Radek*
Professor of Psychology, Elmhurst College, Illinois, USA
Corresponding Author : Kathy Sexton-Radek
Professor of Psychology
Elmhurst College, Illinois, USA
E-mail: [email protected]
Received October 06, 2013; Accepted October 10, 2013; Published October 15, 2013
Citation: Radek KS (2013) Insomnia Symptom Presentation and Sleep Aids. J Sleep Disord Ther 2:e122. doi:10.4172/2167-0277.1000e122
Copyright: © 2013 Radek KS. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Sleep Disorders & Therapy

In a recent poll conducted by the National Sleep Foundation, forty-eight percent of Americans report symptoms of Insomnia on a nightly basis. With this, females more so than males, report insomnia symptoms [1]. Adults over sixty-six years were two times more likely to report insomnia symptoms as compared to young adult respondents to the National Sleep Foundation survey. An examination of the responses summarized the impact of poor sleep quality reported on healthcare costs; $14 billion directly and $28 billion indirectly costs are incurred from healthcare services/hospital/nursing home and transportation to services/lost wages, respectfully1. Overall, the Center for Disease Control, reported that 8.6 million people or 4% or the general population of Adults use sleep medications [2]. Further, researchers have reported the high co-occurrence of sleep and psychiatric prescriptions with depression and physical disability as the most common reasons [3,4].
Insomnia is the most prevalent sleep disturbances reported [1]. The treatment pathway indicates the use of sleep hygiene, then cognitive behavioral therapy then short term medication treatment for Insomnia symptoms of difficulties of both falling asleep and staying asleep. The duration and severity of the Insomnia symptoms dictate the entry point and length of time using treatment techniques on this pathway (i.e., transient = 1-3 days; Short-term=no more than 3 weeks; Chronic=3 nights/week for one month or longer) [2]. It is estimated that nearly 25% of all Americans have transient insomnia symptoms and approximately 10% have chronic symptoms of Insomnia [2].
Non-benzodiazepine Hypnotics are the first line of medication intervention. This category includes Zolpidem, Zaleplon, Eszopiclone and Ramelteon. This group of medications is commonly used and is reported as effective. Possible side effects include: drowsiness, dizziness, fatigue, headache, and diarrhea. The drowsiness side effect has been the most commonly reported and clear warning by the Prescribing Care Provider is be given with the educational explanation of the reasoning for the use of the medication for their care. The benzodiazepine category of medications is in second place of common use because of their potential dependence and side effects profiles. Long acting benzodiazepines Flurazepam, Clonazepam and Quazepam along with medium acting benzodiazepines of triazolam, lorazepam, alprazolam and temazepam are used in Insomnia treatment. Also, antidepressant medications such as trazodone, doxepin, amitriptyline and mirtazapine are commonly used with an hour of sleep designation. Last, the herbal supplements, while economical and available without prescription have not been empirically vetted for clinical use. Valarian root, Kava and Tryptophan have been popular for use to self-treat Insomnia. Melatonin has had some empirical study and when monitored and prescribed correctly, is useful [5].
Responsible examination of the prevalence figures reported suggests an unmet need. Further, the treatment pathways do not suggest an association between treatment and symptom presentation. Sensible approaches suggest the use of self-help and cognitive behavioral methods for transient, short-term and moderate levels of chronic Insomnia. However, data indicating that this is the case is unknown. Such figures would provide both valuable information about the utility of the treatment as well as the specific symptom/treatment need that is to be addressed.

Tables and Figures at a glance

Table icon Table icon Table icon
Table 1 Table 2 Table 3


Table icon Table icon Table icon
Table 4 Table 5 Table 6


Figures at a glance

Figure Figure Figure
Figure 1 Figure 2 Figure 3


Figure Figure Figure
Figure 4 Figure 5 Figure 6
Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Article Usage

  • Total views: 11828
  • [From(publication date):
    November-2013 - Oct 21, 2018]
  • Breakdown by view type
  • HTML page views : 8058
  • PDF downloads : 3770

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version